Web software for a molecular-AI company, through to acquisition
Molab.ai builds AI that predicts how molecules will behave, the ADME properties that decide whether a drug candidate is worth pursuing. We handled the software development around their website through a period of fast growth, and built a site the team could run themselves. Molab.ai was acquired by Cresset in 2025.
Read the case study


